ArticleExperimental and therapeutic medicine2016

LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-β1 signaling activity following subarachnoid hemorrhage in rats.

Fan Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.